CompaniesGAVIS PHARMACEUTICALS

GAVIS PHARMACEUTICALS

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

1,134

By Phase

PHASE1: 2PHASE3: 1PHASE2: 1

By Status

COMPLETED: 2TERMINATED: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
Today
NCT00959959
NCT01709734
Hover over trial bars to see details

Recent Trials

NCT02729376Lead Sponsor
Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone
PHASE1Completed
6 participants
Started: Mar 31, 2016 · Completed: Apr 30, 2016
NCT02438007Lead Sponsor
A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC
PHASE3Terminated
953 participants
Started: Jun 30, 2015 · Completed: Nov 30, 2016
NCT01709734Lead Sponsor
A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer
PHASE2Terminated
126 participants
Started: Dec 31, 2012 · Completed: Sep 30, 2016
NCT00959959Lead Sponsor
ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer
PHASE1Completed
49 participants
Started: Oct 31, 2009 · Completed: Aug 31, 2012
Related Companies
Lupin----------------------------------------if You Believe Any Of This Information Is Incorrect
acquired